ALDOC and gastric cancer: ALDOC demonstrates significant overexpression in gastric cancer (GC) (25) and colorectal cancer (CRC) (26), where it directly promotes tumor proliferation, invasion, and metastasis through glycolytic reprogramming – a hallmark of the Warburg effect.